NCT00585364View on ClinicalTrials.gov

Mechanisms of Immune Tolerance and Inflammation in Patients With Cystic Fibrosis With ABPA

CompletedOBSERVATIONAL
Enrollment

79

Participants

Timeline

Start Date

March 31, 2005

Primary Completion Date

December 31, 2010

Study Completion Date

December 31, 2010

Conditions
Cystic FibrosisAllergic Bronchopulmonary Aspergillosis
Trial Locations (1)

15213

Children's Hospital of Pittsburgh of UPMC, Pittsburgh

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

University of Pittsburgh

OTHER

NCT00585364 - Mechanisms of Immune Tolerance and Inflammation in Patients With Cystic Fibrosis With ABPA | Biotech Hunter | Biotech Hunter